Actual Medicinal Product (AMP) Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd)
Stability Information
- Stability
- We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.
- Notes
- There are no stability notes available for this medicine.
- Generic
- Rivastigmine
- Formulation
- Rivastigmine 13.3mg/24hours transdermal patches
-
Rivastigmine
-
Rivastigmine 13.3mg/24hours transdermal patches
-
Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd)
-
-